| 000 | 01707 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517141209.0 | ||
| 264 | 0 | _c20171026 | |
| 008 | 201710s 0 0 eng d | ||
| 022 | _a1873-6815 | ||
| 024 | 7 |
_a10.1016/j.exger.2017.02.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHuang, Min | |
| 245 | 0 | 0 |
_aBerberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease. _h[electronic resource] |
| 260 |
_bExperimental gerontology _c05 2017 |
||
| 300 |
_a25-33 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
| 650 | 0 | 4 |
_aAmyloid Precursor Protein Secretases _xmetabolism |
| 650 | 0 | 4 |
_aAmyloid beta-Peptides _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAspartic Acid Endopeptidases _xmetabolism |
| 650 | 0 | 4 |
_aAutophagy _xdrug effects |
| 650 | 0 | 4 |
_aBerberine _xpharmacology |
| 650 | 0 | 4 |
_aBrain _xpathology |
| 650 | 0 | 4 |
_aCognitive Dysfunction _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMaze Learning _xdrug effects |
| 650 | 0 | 4 |
_aMemory _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 |
_aNeurons _xmetabolism |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 |
_aPlaque, Amyloid _xmetabolism |
| 700 | 1 | _aJiang, Xin | |
| 700 | 1 | _aLiang, Yubin | |
| 700 | 1 | _aLiu, Qiong | |
| 700 | 1 | _aChen, Siyan | |
| 700 | 1 | _aGuo, Yi | |
| 773 | 0 |
_tExperimental gerontology _gvol. 91 _gp. 25-33 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.exger.2017.02.004 _zAvailable from publisher's website |
| 999 |
_c26901908 _d26901908 |
||